Literature DB >> 12707853

Human T-cell lymphotropic virus type I and neurological diseases.

Masahiro Nagai1, Mitsuhiro Osame.   

Abstract

Human T-cell lymphotropic virus type I (HTLV-I) infection is associated with a variety of human diseases. In particular, there are two major diseases caused by HTLV-I infection. One is an aggressive neoplastic disease called adult T-cell leukemia (ATL), and another is a chronic progressive inflammatory neurological disease called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It is still unknown why one virus causes these different diseases. With regard to HAM/TSP, virus-host immunological interactions are an considered to be important cause of this disease. Coexisting high HTLV-I proviral load and HTLV-I-specific T cells (CD4+ T cells and CD8+ T cells) is an important feature of HAM/TSP. Histopathological studies indicate the existence of an inflammatory reaction and HTLV-I-infected cells in the affected lesions of HAM/TSP. Therefore, the immune response to HTLV-I probably contributes to the inflammatory process of the central nervous system lesions in HAM/TSP patients.

Entities:  

Mesh:

Year:  2003        PMID: 12707853     DOI: 10.1080/13550280390194028

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  56 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.

Authors:  S Yashiki; T Fujiyoshi; N Arima; M Osame; M Yoshinaga; Y Nagata; M Tara; K Nomura; A Utsunomiya; S Hanada; K Tajima; S Sonoda
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

3.  Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.

Authors:  S Hausmann; W E Biddison; K J Smith; Y H Ding; D N Garboczi; U Utz; D C Wiley; K W Wucherpfennig
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

4.  Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.

Authors:  W E Biddison; R Kubota; T Kawanishi; D D Taub; W W Cruikshank; D M Center; E W Connor; U Utz; S Jacobson
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

5.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

8.  Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.

Authors:  S Koenig; R M Woods; Y A Brewah; A J Newell; G M Jones; E Boone; J W Adelsberger; M W Baseler; S M Robinson; S Jacobson
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

9.  Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.

Authors:  T J Lehky; C H Fox; S Koenig; M C Levin; N Flerlage; S Izumo; E Sato; C S Raine; M Osame; S Jacobson
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

10.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  24 in total

1.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

2.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

3.  Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis.

Authors:  Weimin Wang; Jiansuo Zhou; Juan Shi; Yaxi Zhang; Shilian Liu; Yanxin Liu; Dexian Zheng
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 4.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

6.  Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.

Authors:  Sebastián Quintremil; Carolina Alberti; Matías Rivera; Fernando Medina; Javier Puente; Luis Cartier; Eugenio Ramírez; Yuetsu Tanaka; M Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

Review 7.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.

Authors:  Cynthia A Pise-Masison; Michael Radonovich; Kathleen Dohoney; John C Morris; Deirdre O'Mahony; Min-Jung Lee; Jane Trepel; Thomas A Waldmann; John E Janik; John N Brady
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

9.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease.

Authors:  Christian Grant; Unsong Oh; Karen Yao; Yoshihisa Yamano; Steven Jacobson
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.